Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults.
Clin Exp Rheumatol. 2020 Jan-Feb;38(1):27-34. Epub 2019 Apr 16.
Clin Exp Rheumatol. 2020.
PMID: 31025924
Free article.
Clinical Trial.